Kezar Life Sciences Inc
NASDAQ:KZR
Income Statement
Earnings Waterfall
Kezar Life Sciences Inc
Revenue
|
7m
USD
|
Operating Expenses
|
-112.2m
USD
|
Operating Income
|
-105.2m
USD
|
Other Expenses
|
3.4m
USD
|
Net Income
|
-101.9m
USD
|
Income Statement
Kezar Life Sciences Inc
Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
7
N/A
|
7
N/A
|
|
Operating Income | ||||||||||||||||||||||||||
Operating Expenses |
(9)
|
(12)
|
(17)
|
(21)
|
(25)
|
(28)
|
(30)
|
(34)
|
(37)
|
(40)
|
(40)
|
(42)
|
(43)
|
(46)
|
(49)
|
(52)
|
(55)
|
(57)
|
(61)
|
(65)
|
(71)
|
(80)
|
(90)
|
(104)
|
(112)
|
|
Selling, General & Administrative |
(2)
|
(3)
|
(5)
|
(6)
|
(7)
|
(7)
|
(8)
|
(9)
|
(10)
|
(11)
|
(11)
|
(12)
|
(12)
|
(13)
|
(14)
|
(14)
|
(16)
|
(17)
|
(18)
|
(19)
|
(20)
|
(21)
|
(22)
|
(26)
|
(27)
|
|
Research & Development |
(6)
|
(8)
|
(12)
|
(15)
|
(18)
|
(20)
|
(22)
|
(25)
|
(27)
|
(29)
|
(29)
|
(30)
|
(31)
|
(33)
|
(35)
|
(37)
|
(39)
|
(41)
|
(43)
|
(46)
|
(51)
|
(58)
|
(68)
|
(78)
|
(86)
|
|
Operating Income |
(9)
N/A
|
(12)
-32%
|
(17)
-44%
|
(21)
-24%
|
(25)
-19%
|
(28)
-13%
|
(30)
-9%
|
(34)
-11%
|
(37)
-11%
|
(40)
-6%
|
(40)
-1%
|
(42)
-5%
|
(43)
-3%
|
(46)
-6%
|
(49)
-7%
|
(52)
-6%
|
(55)
-6%
|
(57)
-5%
|
(61)
-6%
|
(65)
-7%
|
(71)
-9%
|
(80)
-12%
|
(90)
-13%
|
(97)
-7%
|
(105)
-9%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
1
|
1
|
2
|
2
|
3
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
(0)
|
(0)
|
1
|
3
|
5
|
8
|
9
|
10
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
|
Pre-Tax Income |
(9)
N/A
|
(11)
-32%
|
(16)
-44%
|
(20)
-22%
|
(23)
-18%
|
(26)
-12%
|
(28)
-8%
|
(31)
-13%
|
(35)
-12%
|
(37)
-7%
|
(38)
-2%
|
(40)
-6%
|
(42)
-3%
|
(45)
-7%
|
(48)
-8%
|
(51)
-7%
|
(55)
-6%
|
(58)
-6%
|
(61)
-6%
|
(64)
-6%
|
(68)
-6%
|
(74)
-9%
|
(83)
-11%
|
(88)
-6%
|
(102)
-16%
|
|
Net Income | ||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(9)
|
(11)
|
(16)
|
(20)
|
(23)
|
(26)
|
(28)
|
(31)
|
(35)
|
(37)
|
(38)
|
(40)
|
(42)
|
(45)
|
(48)
|
(51)
|
(55)
|
(58)
|
(61)
|
(64)
|
(68)
|
(74)
|
(83)
|
(88)
|
(102)
|
|
Net Income (Common) |
(9)
N/A
|
(11)
-32%
|
(16)
-44%
|
(20)
-22%
|
(23)
-18%
|
(26)
-12%
|
(28)
-8%
|
(31)
-13%
|
(35)
-12%
|
(37)
-7%
|
(38)
-2%
|
(40)
-6%
|
(42)
-3%
|
(45)
-7%
|
(48)
-8%
|
(51)
-7%
|
(55)
-6%
|
(58)
-6%
|
(61)
-6%
|
(64)
-6%
|
(68)
-6%
|
(74)
-9%
|
(83)
-11%
|
(88)
-6%
|
(102)
-16%
|
|
EPS (Diluted) |
-0.46
N/A
|
-0.61
-33%
|
-0.86
-41%
|
-1.05
-22%
|
-2.26
-115%
|
-1.35
+40%
|
-1.46
-8%
|
-1.64
-12%
|
-1.84
-12%
|
-1.13
+39%
|
-0.89
+21%
|
-0.8
+10%
|
-0.95
-19%
|
-0.87
+8%
|
-0.92
-6%
|
-1
-9%
|
-1.04
-4%
|
-0.95
+9%
|
-0.94
+1%
|
-0.89
+5%
|
-1.01
-13%
|
-1.02
-1%
|
-1.15
-13%
|
-1.22
-6%
|
-1.4
-15%
|